Another single-chamber leadless pacemaker has officially hit the market. 

Sean Pokorney, MD, director of the arrhythmia core lab, Duke Clinical Research Institute, assistant professor of Medicine, Duke University, discusses a late-breaking ACC 2022 study that shows mortality is higher in patients with implantable electrophysiology (EP) device infections where the leads are not explanted.

A Chinese study of 2.8 million participants found that 94% of users flagged for AFib indeed have the heart rhythm disorder.

Mass General cardiologist and Harvard professor Ami Bhatt, MD, predicts upcoming paradigm shifts in cardiology over the next decade. 

Nearly 19,000 patients with newly diagnosed atrial fibrillation were included in the team's analysis. 

Researchers explored data from the National Inpatient Sample, sharing their findings in the American Journal of Cardiology.

Researchers examined data from 39 different studies, focusing on mortality rates and adverse cardiovascular outcomes.